Important note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date.
PRNewswire - December 7, 2006
The findings, published in the Dec. 8 issue of Science, found that because malaria increases the viral load of an HIV-infected person on the order of 10 times, it makes HIV more transmissible to a sex partner. Conversely, HIV may play a role in the geographic expansion of malaria in Africa because HIV-infected persons are more susceptible to malaria infections due to their already-compromised immune systems, according to study co-authored by Laith J. Abu-Raddad, Ph.D., Padmaja Patnaik, Ph.D. and James G. Kublin M.D., M.P.H.
"While HIV/AIDS is predominantly spreading through sexual intercourse, this biological co-factor induced by malaria has contributed considerably to the spread of HIV by increasing HIV transmission probability per sexual act," said Abu-Raddad, an HIV/AIDS research scientist in the Hutchinson Center's Statistical Center for HIV/AIDS Research and Prevention and the Center for Studies in Demography and Ecology at the University of Washington.
"In turn, the weakening of the immune system by HIV infection has fueled a rise in adult malaria-infection rates and may have facilitated the expansion of malaria in Africa," said Kublin, an HIV/AIDS scientist in the Hutchinson Center's Clinical Research Division.
Using a mathematical model designed by Abu-Raddad that was based on HIV and malaria co-infection data in Malawi measured and collected by Kublin, the scientists for the first time were able to assess quantitatively the impact of malaria on HIV and vice versa, as well as provide the first assessment of the role of "blips" in HIV viral load seen during HIV co-infection with some other diseases. They estimate that tens of thousands of HIV infections and millions of malaria cases are likely the result of this co-infection.
Using the town of Kisumu, Kenya on the shore of Lake Victoria as an example, Abu-Raddad estimates that 5 percent of all HIV infections are attributed to the heightened HIV viral load induced by malaria. "In Kisumu, we estimate that 10 percent of adult malaria episodes are attributed to HIV," he said.
That translates into 8,500 excess HIV infections and 980,000 excess malaria episodes since 1980 in a town with an adult population of about 200,000, the researchers said.
Kublin said that these findings suggest that other co-infections such as genital herpes or tuberculosis may have also contributed to the rapid expansion of HIV in Africa.
The study's findings have implications for public health, Kublin said. "We can reduce HIV/AIDS transmission by concomitantly treating HIV/AIDS co- infections with malaria as well as other diseases," he said.
"The global public-health system's failure to deal with the challenge of HIV/AIDS contributes directly to its failure to tackle other public-health challenges such as malaria and tuberculosis," Abu-Raddad said. "As long as HIV/AIDS continues to spread, it will aggravate the difficulties we face with these other diseases and may contribute to the emergence of more lethal or drug-resistant strains of these infections," Kublin added.
The study was funded by the Center for AIDS Research (CFAR) at the University of Washington through the Mathematical Modeling Program for HIV/STD Research. The HIV Vaccine Trials Network at Fred Hutchinson Cancer Research Center provided partial support for this work.
About Fred Hutchinson Cancer Research Center -- The Hutchinson Center's interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Center researchers, including three Nobel laureates, bring a relentless pursuit and passion for health, knowledge and hope to their work and to the world. For more information, please visit fhcrc.org.
CONTACT: Dean Forbes, +1-206-667-2896, or dforbes@fhcrc.org
SOURCE Fred Hutchinson Cancer Research Center
http://www.fhcrc.org
061207
PR061218
Copyright © 2006 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019 http://www.prnewswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .